Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-05-03

Clinical Trial Update: Study for the Treatment of Chronic Idiopathic Urticaria With High Doses of AERIUS (Desloratadine) (Study P04849) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating high-dose desloratadine (AERIUS) for chronic idiopathic urticaria; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aerius (cetirizine)

Snippet

Sponsor: Organon and Co | Conditions: Chronic Idiopathic Urticaria | Phase 4 | Status: COMPLETED | Results posted: 2010-05-03